Effectiveness of the Dry Needling Approach in Patients With Tension-Type Headache

Sponsor
Universidad de Zaragoza (Other)
Overall Status
Recruiting
CT.gov ID
NCT06108180
Collaborator
(none)
30
1
2
1.4
21.2

Study Details

Study Description

Brief Summary

Randomized Single-Blind Clinical Trial in which the treatment will be administered through 3 sessions of dry needling in the cervical, cranial, and facial musculature in patients with frequent and chronic tension-type headache.

Condition or Disease Intervention/Treatment Phase
  • Other: Dry Needling
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effectiveness of the Dry Needling Approach in Patients With Tension-Type Headache
Anticipated Study Start Date :
Oct 23, 2023
Anticipated Primary Completion Date :
Oct 23, 2023
Anticipated Study Completion Date :
Dec 5, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dry Needling group

Other: Dry Needling
3 treatment to eliminate active trigger points that patients have

No Intervention: Control group

Outcome Measures

Primary Outcome Measures

  1. Active trigger points [1 month]

    The investigators assess the sensitivity of trigger points using algometry to determine which points reproduce the participants tensional-type headache.

Secondary Outcome Measures

  1. cervical ROM [1 month]

    general cervical range of movement, upper and lower cervical

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients with a diagnosis of tension headache according to IHS
Exclusion Criteria:
  • Documented major trauma through medical history in the cervical area and/or recent surgery.

  • Pregnancy.

  • Generalized pain.

  • Inflammatory, hormonal, or neurological disorders.

  • Tendon disorders in the upper extremities.

  • Severe psychiatric illnesses.

  • Inability to complete the form in Spanish.

  • Having a pacemaker (due to the use of equipment with magnetic sensors).

  • Specific contraindications to invasive or conservative physiotherapy (infection, fever, hypothyroidism, wounds in the puncture area, metal allergies, cancer, systemic diseases, or belonephobia).

  • Having received physiotherapy treatment for the condition in the past month.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centro Clínico de Fisioterapia OMT-E Zaragoza Spain 50009

Sponsors and Collaborators

  • Universidad de Zaragoza

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sofía Monti Ballano, Principal Investigator, Universidad de Zaragoza
ClinicalTrials.gov Identifier:
NCT06108180
Other Study ID Numbers:
  • RAT 2023-195
First Posted:
Oct 30, 2023
Last Update Posted:
Nov 1, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 1, 2023